Paper40036070
Two DRB3 residues predictively associate with the progression to type 1 diabetes among DR3 carriers.
Zhao LP and 10 others. JCI Insight, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Two DRB3 residues predictively associate with the progression to type 1 diabetes among DR3 carriers. Papers, record 40036070. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40036070
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Two DRB3 residues predictively associate with the progression to type 1 diabetes among DR3 carriers.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| HLA-DRB3 Chains | Major topic |
| Humans | |
| Disease Progression | |
| Female | |
| Male | |
| Genetic Predisposition to Disease | |
| Adult | |
| Alleles | |
| Haplotypes | |
| Heterozygote | |
| Adolescent | |
| HLA-DRB1 Chains | |
| Child |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DK132406 | NIDDK NIH HHS | United States | R01DK132406 | PubMed and NIH |
Source NIH RePORTER
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30962219 | Genetic Variation Within the HLA-DRA1 Gene Modulates Susceptibility to Type 1 Diabetes in HLA-DR3 Homozygotes. | Diabetes | 2019 | https://conductscience.org/library/papers/30962219 | PubMed |
| 2 | 2786876 | mRNA abundance, rather than differences in subunit assembly, determine differential expression of HLA-DR beta 1 and -DR beta 3 molecules. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2786876 | PubMed |
| 3 | 9529148 | Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. | Immunity | 1998 | https://conductscience.org/library/papers/9529148 | PubMed |
| 4 | 3309680 | HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. | Nature | 1987 | https://conductscience.org/library/papers/3309680 | PubMed |
| 5 | 30192820 | The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression. | PLoS One | 2018 | https://conductscience.org/library/papers/30192820 | PubMed |
| 6 | 32561620 | T-Cell Epitopes and Neo-epitopes in Type 1 Diabetes: A Comprehensive Update and Reappraisal. | Diabetes | 2020 | https://conductscience.org/library/papers/32561620 | PubMed |
| 7 | 38498185 | HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07). | Diabetes Care | 2024 | https://conductscience.org/library/papers/38498185 | PubMed |
| 8 | 36871844 | CIPDB: A biological structure databank for studying cation and π interactions. | Drug Discov Today | 2023 | https://conductscience.org/library/papers/36871844 | PubMed |
| 9 | 31571372 | A modified flow cytometry method for objective estimation of human CD4+ regulatory T cells (CD4+ Tregs) in peripheral blood, via CD4/CD25/CD45RO/FoxP3 labeling. | Cytometry B Clin Cytom | 2020 | https://conductscience.org/library/papers/31571372 | PubMed |
| 10 | 26707565 | Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides. | Eur J Immunol | 2016 | https://conductscience.org/library/papers/26707565 | PubMed |
| 11 | 10426278 | MHC-peptide ligand interactions establish a functional threshold for antigen-specific T cell recognition. | Hum Immunol | 1999 | https://conductscience.org/library/papers/10426278 | PubMed |
| 12 | 31183978 | Factors affecting HLA expression: A review. | Int J Immunogenet | 2019 | https://conductscience.org/library/papers/31183978 | PubMed |
| 13 | 8316295 | Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. | Nature | 1993 | https://conductscience.org/library/papers/8316295 | PubMed |
| 14 | 8145819 | Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. | Nature | 1994 | https://conductscience.org/library/papers/8145819 | PubMed |
| 15 | 28358037 | Type 1 diabetes mellitus. | Nat Rev Dis Primers | 2017 | https://conductscience.org/library/papers/28358037 | PubMed |
| 16 | 31331989 | The Immunoreactive Platform of the Pancreatic Islets Influences the Development of Autoreactivity. | Diabetes | 2019 | https://conductscience.org/library/papers/31331989 | PubMed |
| 17 | 18556337 | Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). | Diabetes | 2008 | https://conductscience.org/library/papers/18556337 | PubMed |
| 18 | 26027777 | An integrated genotyping approach for HLA and other complex genetic systems. | Hum Immunol | 2015 | https://conductscience.org/library/papers/26027777 | PubMed |
| 19 | 15809348 | Understanding how combinations of HLA and KIR genes influence disease. | J Exp Med | 2005 | https://conductscience.org/library/papers/15809348 | PubMed |
| 20 | 11376336 | Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. | Nat Immunol | 2001 | https://conductscience.org/library/papers/11376336 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42851930 | Artificial intelligence-driven therapeutics for disease modification in type 1 diabetes: a digital public health and clinical translation framework. | Front Public Health | 2026 | https://conductscience.org/library/papers/42851930 | PubMed |
| 41335420 | Profiling Associations Between IGHG-FCGR Ligand-Receptor Interactions and Disease Progression From Stage 1 and 2 to Stage 3 Type 1 Diabetes. | Diabetes | 2026 | https://conductscience.org/library/papers/41335420 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HLA-DRB1 | 3123 | PubTator's text mining | https://conductscience.org/library/genes/3123 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40036070
GET https://conductscience.org/api/papers/v1/40036070/references?page=2